Top 5 Things YOU Should
Know About Any COVID-
19 Vaccine!!
Medical News
 The last year was definitely a shocker to the world since the
appearance of the corona virus pandemic. After intensive research;
scientists were able to develop a vaccine that prevents from getting
the covid virus. However, the different types of vaccines made
confusion amongst people on which is better to use! And whether it
is safe or not? One fact for sure is that This vaccine works like
any other ordinary vaccine except for one thing that we’re going to
discuss along the article. So here are the top 5 things you
should know about the CORONA VIRUS VACCINES
Process of vaccination
1- How Does The Vaccine Works?
 Vaccines normally contain weakened or inactive substants of a particular antigen that
triggers an immune response within the body. This inactive version will not cause that
disease in the person receiving the vaccine. However, it will boost their immune system
to respond as if it would have on its first reaction to the actual germ.
 Some vaccines require several doses, given weeks or months apart which is sometimes
needed to permit the production of long-lived antibodies and development of memory
cells. Hence, the body is trained to fight the specific “disease-causing” organism,
building up a specific memory of the pathogen to rapidly fight it if and when exposed in
the future.
 As far as the covid-19 pandemic is concerned, its contagious nature makes it impossible
for people to proceed their regular daily lifestyles without getting infected; therefore,
getting vaccinated is the only solution to at least reduce the danger of infection.
2- The difference Between The Various
Types of Covid-19 Vaccines
 Various types of COVID-19 vaccines have been developed after in-depth researches done by more than
6000 scientists all over the globe; and are still in the progress of developing other versions for possible
alterations of the various. Now, here are the most common types of vaccines and their functions:

 • Protein-based vaccines: use harmless fragments of proteins or protein shells that mimic the COVID-
19 virus to generate an immune response safely.

 • Inactivated virus vaccines: use a form of the virus that has been inactivated so it does not cause the
disease, but still develop an immune response.

 • Viral vector vaccines: which use a harmless virus as a vassel that holds the coronavirus proteins to
safely generate an immune response.

 • Nucleic acid (mRNA) vaccines: take genetically engineered RNA to generate a protein that itself safely
stimulates an immune response. It uses a molecule as its base, a molecular cousin of DNA, mRNA has
instructions to build specific proteins i.e, the structure that sticks off the virus's surface and used to
infect human cells.
 Once it gets inside the body, the vaccine work is to instructs human cells to build this protein so the immune
system learns to recognize and attack it.
3- The Most Used Covid-19 Vaccines
1. Pfizer vaccine
 This vaccine was developed by Pfizer and German biotechnology company BioNTech.
Their statistics show 95% effectiveness at preventing COVID-19; The vaccine is given
in two doses three weeks apart).
 On December 11, 2020, the Pfizer-BioNTech vaccine became the first COVID-19
vaccine to be authorized for emergency use by the U.S. Food and Drug Administration
(FDA).
 Several countries have already authorized the vaccine for emergency use also, including
Argentina, the U.K., Chile and Singapore. the European Union followed the latter on
Dec. 21. According to The New York Times reports: Bahrain, Canada, Saudi Arabia and
Switzerland have completely approved and signed up for the vaccine. However, The
Associated Press reported that Australia gave the vaccine "provisional approval" for use
to whom aged 16 and over on Jan. 25 The Associated Press reported.
 Pfizer announced later on March 31 that the vaccine was 100% effective among
children ages 12 to 15 in preventing COVID-19 as far as the late-stage clinical trial is
concerned.
2. Sinopharm vaccine
 China National Pharmaceutical Group/ Sinopharm collaborated with the Beijing Institute of
Biological Products to develop a vaccine that prevents virus transmission. Using an inactivated
coronavirus, which is a redesigned version of SARS-CoV-2 (the cause of severe acute
respiratory distress syndrome) that cannot replicate. Sinopharm announced in late December
that the vaccine, called BBIBP-CorV, is more than 79 percent effective, based on preliminary
data from late-stage clinical trials; however, the company has not published the data.
According to Live Science, China granted Sinopharm permission to vaccinate construction
workers, diplomats, and students with one of its two COVID-19 vaccine candidates, including
BBIBP-CorV, in the summer of 2020. According to the company's chairman, nearly 1 million
people had received the vaccines by November.
In September, the UAE authorized Sinopharm vaccine for emergency use, until December, the
vaccine was approved. According to the Times, China also approved the vaccine in December
in all its institutions, and Egypt authorized it for emergency use in January 2021. The vaccine is
administered in two doses separated in three weeks.
 RMH (the Russian Ministry of Health) announced that Gamaleya Research Institute created a
coronavirus vaccine called Sputnik V, named after the World’s first artificial satellite launched.
The latter contains two genetically modified common cold viruses that also has genes code for
the spike protein of coronavirus.
3. SPUTNIK
 According to data gathered from early clinical trials Russia stated in November that the
vaccine is more than 91.4% effective in hindering COVID-19. On Feb. 2, the Lancet
reported the efficiency of the vaccine with 91.6% from data based on a late-stage trial.
 In November 2020, a mass vaccination campaign was conducted by the Russian
government offering the vaccine to all of the citizens. However, there were some
sayings about Russia approving the vaccine in August for limited use without sufficient
data from human trials.
 the Times reported that Argentina, Belarus and Serbia have also approved the vaccine
for emergency use late in November as well.
4. AstraZeneca Vaccine
 AstraZeneca (The Oxford University and pharmaceutical company) came up with what is said to be about 70% effective at inhibiting COVID-19.
According to the clinical trials, adjusting the dose appeared to boost its efficacy.
 Allegedly, this vaccine is about 62% effective. Two full-size doses are given, the second dose come after 28 days from the first. However, the primer
analysis showed that in people given a half-dose followed by a full dose (which is done unknowingly by the participants) the vaccine was surprisingly
90% effective. However, scientists, or at least some of them, have questioned those results and whether they are representative.
 During the late December, the Oxford-AstraZeneca vaccine was authorized by the U.K along with Argentina for emergency use followed by Mexico
and India in January. according to the Times, The EU's “European Medicines Agency” permitted the vaccine for adults on Jan. 29.
 For the surprising part!! numerous countries paused temporarily their use of the vaccine when reporting of blood clots with abnormal bleeding among
particular vaccinated people. Live Science reported that the EU's European Medicines Agency terminated that the vaccine does not increase the
general incidence of blood clots; however, there is no direct link to several rare clotting disorders.
 The committee immediately started a thorough investigation into these rare clotting incidents and found that they are indeed related to the vaccine.
The reason why and how it triggers the clotting remains unknown. Blood clots with low platelet counts must be listed as possible side effects of the
vaccine, because these effects can appear in approximately "one in 100,000" vaccinated people; even though the accurate rate at which vaccinated
people form the clots is still unknown.


4- Covid-19 Vaccine and Chronic Illnesses
 COVID-19 vaccines are administered to patients with underlying
medical conditions as long as they do not show severe or instant
allergic reaction to any of the substances in the vaccine. As far as the
limited vaccines supplies are concerned, the vaccination is at best
recommended as a priority for those with chronic diseases such as:
chronic respiratory disease, chronic cardiovascular disease, obesity and
diabetes, all have been listed as highly at the risk of severe and
complicated COVID-19 illness that would lead to hospitalization.
5- Covid-19 Pregnancy and Children!!
 Pregnant women are also at higher risk of getting severe COVID-
19 condition compared to women who are not pregnant. It has been shown
through statistics that COVID-19 has been associated with an increasing risk
namely preterm birth and possible malfunction in fetus’s organs.
 WHO recommends the avoidance of COVID-19 vaccine during pregnancy,
unless if there is a possible benefit of vaccinating a pregnant woman that
outweighs the probable vaccine risks, like those health employees that are at
high risk of exposure and along with pregnant women having comorbidities
placing them in a high-risk category for severe COVID-19.
 As far as children are concerned the initial doses of the vaccines are sent to
countries for those who are health workers and people with higher risk of
severe illness caused by the virus, for instance the elderly and those with
chronical conditions, and are most unlikely to be given to children. The
selection of these populations have been very spicific to help diminish
morbidity from COVID-19 and to help protect health establishments that
serve everyone. it should be taken into acount keeping up with the updates
related with this matter because it's still under study.
Important summary
 Getting the vaccine or not become the debate of the year! Since its release,
people are still wondering what if it’s not effective, what if it’s all a scam, what
if I could have the rare side effects, which one is better to use! Even though the
statistics were shown and studies were proven, there's still vague conception to
people about the COVID-19 vaccine.
 To do it or not is really up to the person and his/her health condition and just
hoping for the best to happen, because people’s bodies differ and their
mechanisms also differ. The only way to know whether to have the vaccine
(any one of the list above) or not is by running some blood tests and see if your
body is ready to receive it. We are not advocates for any part; however, we
encourage global health awareness.
 Don't hesitate to share with us your experience with the COVID-19 Vaccine;
wether you took it or not to help everyone clear the vision concerning this
controversial issue!
Source: https://www.space-medical.com/2021/08/5-things-you-should-know-
about-any.html



Top 5 things you should know about any covid 19 vaccine

  • 1.
    Top 5 ThingsYOU Should Know About Any COVID- 19 Vaccine!! Medical News
  • 2.
     The lastyear was definitely a shocker to the world since the appearance of the corona virus pandemic. After intensive research; scientists were able to develop a vaccine that prevents from getting the covid virus. However, the different types of vaccines made confusion amongst people on which is better to use! And whether it is safe or not? One fact for sure is that This vaccine works like any other ordinary vaccine except for one thing that we’re going to discuss along the article. So here are the top 5 things you should know about the CORONA VIRUS VACCINES
  • 3.
  • 4.
    1- How DoesThe Vaccine Works?  Vaccines normally contain weakened or inactive substants of a particular antigen that triggers an immune response within the body. This inactive version will not cause that disease in the person receiving the vaccine. However, it will boost their immune system to respond as if it would have on its first reaction to the actual germ.  Some vaccines require several doses, given weeks or months apart which is sometimes needed to permit the production of long-lived antibodies and development of memory cells. Hence, the body is trained to fight the specific “disease-causing” organism, building up a specific memory of the pathogen to rapidly fight it if and when exposed in the future.  As far as the covid-19 pandemic is concerned, its contagious nature makes it impossible for people to proceed their regular daily lifestyles without getting infected; therefore, getting vaccinated is the only solution to at least reduce the danger of infection.
  • 5.
    2- The differenceBetween The Various Types of Covid-19 Vaccines
  • 6.
     Various typesof COVID-19 vaccines have been developed after in-depth researches done by more than 6000 scientists all over the globe; and are still in the progress of developing other versions for possible alterations of the various. Now, here are the most common types of vaccines and their functions:   • Protein-based vaccines: use harmless fragments of proteins or protein shells that mimic the COVID- 19 virus to generate an immune response safely.   • Inactivated virus vaccines: use a form of the virus that has been inactivated so it does not cause the disease, but still develop an immune response.   • Viral vector vaccines: which use a harmless virus as a vassel that holds the coronavirus proteins to safely generate an immune response.   • Nucleic acid (mRNA) vaccines: take genetically engineered RNA to generate a protein that itself safely stimulates an immune response. It uses a molecule as its base, a molecular cousin of DNA, mRNA has instructions to build specific proteins i.e, the structure that sticks off the virus's surface and used to infect human cells.  Once it gets inside the body, the vaccine work is to instructs human cells to build this protein so the immune system learns to recognize and attack it.
  • 7.
    3- The MostUsed Covid-19 Vaccines
  • 8.
    1. Pfizer vaccine This vaccine was developed by Pfizer and German biotechnology company BioNTech. Their statistics show 95% effectiveness at preventing COVID-19; The vaccine is given in two doses three weeks apart).  On December 11, 2020, the Pfizer-BioNTech vaccine became the first COVID-19 vaccine to be authorized for emergency use by the U.S. Food and Drug Administration (FDA).  Several countries have already authorized the vaccine for emergency use also, including Argentina, the U.K., Chile and Singapore. the European Union followed the latter on Dec. 21. According to The New York Times reports: Bahrain, Canada, Saudi Arabia and Switzerland have completely approved and signed up for the vaccine. However, The Associated Press reported that Australia gave the vaccine "provisional approval" for use to whom aged 16 and over on Jan. 25 The Associated Press reported.  Pfizer announced later on March 31 that the vaccine was 100% effective among children ages 12 to 15 in preventing COVID-19 as far as the late-stage clinical trial is concerned.
  • 9.
    2. Sinopharm vaccine China National Pharmaceutical Group/ Sinopharm collaborated with the Beijing Institute of Biological Products to develop a vaccine that prevents virus transmission. Using an inactivated coronavirus, which is a redesigned version of SARS-CoV-2 (the cause of severe acute respiratory distress syndrome) that cannot replicate. Sinopharm announced in late December that the vaccine, called BBIBP-CorV, is more than 79 percent effective, based on preliminary data from late-stage clinical trials; however, the company has not published the data. According to Live Science, China granted Sinopharm permission to vaccinate construction workers, diplomats, and students with one of its two COVID-19 vaccine candidates, including BBIBP-CorV, in the summer of 2020. According to the company's chairman, nearly 1 million people had received the vaccines by November. In September, the UAE authorized Sinopharm vaccine for emergency use, until December, the vaccine was approved. According to the Times, China also approved the vaccine in December in all its institutions, and Egypt authorized it for emergency use in January 2021. The vaccine is administered in two doses separated in three weeks.  RMH (the Russian Ministry of Health) announced that Gamaleya Research Institute created a coronavirus vaccine called Sputnik V, named after the World’s first artificial satellite launched. The latter contains two genetically modified common cold viruses that also has genes code for the spike protein of coronavirus.
  • 10.
    3. SPUTNIK  Accordingto data gathered from early clinical trials Russia stated in November that the vaccine is more than 91.4% effective in hindering COVID-19. On Feb. 2, the Lancet reported the efficiency of the vaccine with 91.6% from data based on a late-stage trial.  In November 2020, a mass vaccination campaign was conducted by the Russian government offering the vaccine to all of the citizens. However, there were some sayings about Russia approving the vaccine in August for limited use without sufficient data from human trials.  the Times reported that Argentina, Belarus and Serbia have also approved the vaccine for emergency use late in November as well.
  • 11.
    4. AstraZeneca Vaccine AstraZeneca (The Oxford University and pharmaceutical company) came up with what is said to be about 70% effective at inhibiting COVID-19. According to the clinical trials, adjusting the dose appeared to boost its efficacy.  Allegedly, this vaccine is about 62% effective. Two full-size doses are given, the second dose come after 28 days from the first. However, the primer analysis showed that in people given a half-dose followed by a full dose (which is done unknowingly by the participants) the vaccine was surprisingly 90% effective. However, scientists, or at least some of them, have questioned those results and whether they are representative.  During the late December, the Oxford-AstraZeneca vaccine was authorized by the U.K along with Argentina for emergency use followed by Mexico and India in January. according to the Times, The EU's “European Medicines Agency” permitted the vaccine for adults on Jan. 29.  For the surprising part!! numerous countries paused temporarily their use of the vaccine when reporting of blood clots with abnormal bleeding among particular vaccinated people. Live Science reported that the EU's European Medicines Agency terminated that the vaccine does not increase the general incidence of blood clots; however, there is no direct link to several rare clotting disorders.  The committee immediately started a thorough investigation into these rare clotting incidents and found that they are indeed related to the vaccine. The reason why and how it triggers the clotting remains unknown. Blood clots with low platelet counts must be listed as possible side effects of the vaccine, because these effects can appear in approximately "one in 100,000" vaccinated people; even though the accurate rate at which vaccinated people form the clots is still unknown.  
  • 12.
    4- Covid-19 Vaccineand Chronic Illnesses  COVID-19 vaccines are administered to patients with underlying medical conditions as long as they do not show severe or instant allergic reaction to any of the substances in the vaccine. As far as the limited vaccines supplies are concerned, the vaccination is at best recommended as a priority for those with chronic diseases such as: chronic respiratory disease, chronic cardiovascular disease, obesity and diabetes, all have been listed as highly at the risk of severe and complicated COVID-19 illness that would lead to hospitalization.
  • 13.
    5- Covid-19 Pregnancyand Children!!  Pregnant women are also at higher risk of getting severe COVID- 19 condition compared to women who are not pregnant. It has been shown through statistics that COVID-19 has been associated with an increasing risk namely preterm birth and possible malfunction in fetus’s organs.  WHO recommends the avoidance of COVID-19 vaccine during pregnancy, unless if there is a possible benefit of vaccinating a pregnant woman that outweighs the probable vaccine risks, like those health employees that are at high risk of exposure and along with pregnant women having comorbidities placing them in a high-risk category for severe COVID-19.  As far as children are concerned the initial doses of the vaccines are sent to countries for those who are health workers and people with higher risk of severe illness caused by the virus, for instance the elderly and those with chronical conditions, and are most unlikely to be given to children. The selection of these populations have been very spicific to help diminish morbidity from COVID-19 and to help protect health establishments that serve everyone. it should be taken into acount keeping up with the updates related with this matter because it's still under study.
  • 14.
    Important summary  Gettingthe vaccine or not become the debate of the year! Since its release, people are still wondering what if it’s not effective, what if it’s all a scam, what if I could have the rare side effects, which one is better to use! Even though the statistics were shown and studies were proven, there's still vague conception to people about the COVID-19 vaccine.  To do it or not is really up to the person and his/her health condition and just hoping for the best to happen, because people’s bodies differ and their mechanisms also differ. The only way to know whether to have the vaccine (any one of the list above) or not is by running some blood tests and see if your body is ready to receive it. We are not advocates for any part; however, we encourage global health awareness.  Don't hesitate to share with us your experience with the COVID-19 Vaccine; wether you took it or not to help everyone clear the vision concerning this controversial issue! Source: https://www.space-medical.com/2021/08/5-things-you-should-know- about-any.html  